ArticleESMO real world data and digital oncology2024

UK multicentre real-world data of the use of cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer.

G Gullick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.